Tandlægeholdingselskabet TBH 2017 ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  10.8% 19.8% 27.4% 34.8% 22.6%  
Credit score (0-100)  24 6 2 0 3  
Credit rating  BB B B C B  
Credit limit (kDKK)  -0.0 0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  -46.1 -7.8 -34.1 -42.3 -46.8  
EBITDA  -1,090 -7.8 -845 -831 -894  
EBIT  -1,090 -7.8 -845 -831 -894  
Pre-tax profit (PTP)  -0.4 -8.5 163.9 136.3 182.6  
Net earnings  -0.4 -8.5 129.6 106.3 142.1  
Pre-tax profit without non-rec. items  -0.4 -8.5 164 136 183  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  75.0 66.5 180 181 212  
Interest-bearing liabilities  8.5 8.5 8.5 8.5 8.5  
Balance sheet total (assets)  289 82.0 294 252 338  

Net Debt  -75.6 -60.1 -154 -213 -130  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -46.1 -7.8 -34.1 -42.3 -46.8  
Gross profit growth  0.0% 83.0% -335.7% -24.1% -10.5%  
Employees  1 0 1 1 1  
Employee growth %  0.0% -100.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  289 82 294 252 338  
Balance sheet change%  0.0% -71.6% 257.8% -14.2% 34.0%  
Added value  -1,090.3 -7.8 -845.3 -830.5 -893.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 -3.0 -4.0 -5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  2,365.9% 100.0% 2,477.0% 1,961.9% 1,911.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.2% -4.2% 87.9% 50.5% 62.3%  
ROI %  0.8% -9.9% 125.3% 72.7% 89.4%  
ROE %  -0.6% -12.0% 105.1% 58.8% 72.2%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  25.9% 81.1% 61.3% 72.0% 62.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  6.9% 767.5% 18.2% 25.7% 14.5%  
Gearing %  11.3% 12.8% 4.7% 4.7% 4.0%  
Net interest  0 0 0 0 0  
Financing costs %  26.5% 7.7% 15.1% 16.0% 13.5%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.5 5.3 2.6 3.6 2.7  
Current Ratio  0.5 5.3 2.6 3.6 2.7  
Cash and cash equivalent  84.1 68.6 162.3 221.5 138.0  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -116.0 66.5 180.1 181.4 212.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -1,090 0 -845 -831 -894  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -1,090 0 -845 -831 -894  
EBIT / employee  -1,090 0 -845 -831 -894  
Net earnings / employee  -0 0 130 106 142